nicorandil has been researched along with Active Hyperemia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anai, R; Araki, M; Inoue, K; Kataoka, M; Miura, T; Naka, Y; Okabe, H; Setoyama, K; Sonoda, S | 1 |
| Fujii, K; Hasegawa, K; Higashino, Y; Ishibuchi, K; Ishii, R; Kakishita, M; Kusumoto, H; Nakabayashi, S; Otsuji, S; Shimatani, Y; Takiuchi, S; Tamaru, H; Taniguchi, Y; Yamamoto, W; Yasuda, S | 1 |
| Arai, T; Masaki, R; Matsumoto, H; Mikuri, M; Ogura, K; Oishi, Y; Okada, N; Sakai, R; Shinke, T; Tanaka, H | 1 |
| Fujii, K; Hirofumi, K; Hiroto, T; Kasumi, I; Katsuyuki, H; Mikio, K; Rui, I; Satoru, O; Shin, T; Shingo, Y; Sho, N; Wataru, Y; Yorihiko, H; Yuji, S; Yusuke, T | 1 |
| Fujii, K; Hashimoto, K; Matsumura, K; Morishita, S; Otagaki, M; Shibutani, H; Shiojima, I; Tsujimoto, S | 1 |
| Amano, T; Ando, H; Fujimoto, M; Kato, D; Kosaka, T; Kuhara, Y; Kumagai, S; Kurita, A; Kuroda, Y; Maeda, K; Mizuno, T; Sakurai, S; Sato, S; Suzuki, A; Takashima, H; Toda, Y; Waseda, K; Watanabe, A | 1 |
| Amano, T; Doh, JH; Kato, D; Kim, HS; Koo, BK; Kurita, A; Lim, WH; Nam, CW; Oi, M; Park, JJ; Park, KW; Pijls, NH; Takashima, H; Toyofuku, M; van Nunen, L; Waseda, K; Yang, HM | 1 |
| Amano, T; Doh, JH; Ishihara, H; Kato, D; Koo, BK; Kurita, A; Lee, JM; Lim, WH; Nam, CW; Oi, M; Takashima, H; Tanaka, N; Toyofuku, M; Waseda, K | 1 |
| Higa, T; Kobayashi, Y; Neishi, Y; Okura, H; Uemura, S; Yoshida, K | 1 |
| Kwon, O; Park, DW | 1 |
1 trial(s) available for nicorandil and Active Hyperemia
| Article | Year |
|---|---|
Influence of caffeine intake on intravenous adenosine-induced fractional flow reserve.
Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Caffeine; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Vasodilator Agents | 2020 |
9 other study(ies) available for nicorandil and Active Hyperemia
| Article | Year |
|---|---|
Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Control Studies; Coronary Angiography; Coronary Stenosis; Drug Therapy, Combination; Electrocardiography; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Incidence; Long QT Syndrome; Male; Middle Aged; Nicorandil; Papaverine; Retrospective Studies; Safety; Tachycardia, Ventricular; Treatment Outcome; Vasodilator Agents | 2021 |
Utility and Validity of Intracoronary Administration of Nicorandil Alone for the Measurement of Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiac Catheterization; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Severity of Illness Index; Time Factors; Vasodilator Agents; Young Adult | 2019 |
Feasibility of intracoronary nicorandil for inducing hyperemia on fractional flow reserve measurement: Comparison with intracoronary papaverine.
Topics: Coronary Angiography; Coronary Circulation; Coronary Stenosis; Feasibility Studies; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Nicorandil; Papaverine; Vasodilator Agents | 2020 |
Additional decrease in fractional flow reserve in the left anterior descending artery after hand-grip exercise during pharmacological coronary hyperemia.
Topics: Cardiac Catheterization; Coronary Angiography; Coronary Stenosis; Fractional Flow Reserve, Myocardial; Hand Strength; Humans; Hyperemia; Nicorandil; Predictive Value of Tests; Vasodilator Agents | 2021 |
Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements.
Topics: Adenosine Triphosphate; Aged; Coronary Angiography; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Hypotension; Infusions, Intra-Arterial; Linear Models; Male; Middle Aged; Nicorandil; Prospective Studies; Vasodilator Agents | 2015 |
Variability of fractional flow reserve according to the methods of hyperemia induction.
Topics: Adenosine; Aged; Coronary Artery Disease; Coronary Circulation; Female; Fractional Flow Reserve, Myocardial; Hemodynamics; Humans; Hyperemia; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Purines; Pyrazoles; Radiography; Reproducibility of Results; Vasodilator Agents | 2015 |
Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis.
Topics: Adenosine; Aged; Aged, 80 and over; Coronary Circulation; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Vasodilator Agents | 2016 |
Additive value of nicorandil on ATP for further inducing hyperemia in patients with an intermediate coronary artery stenosis.
Topics: Adenosine Triphosphate; Aged; Cardiac Catheterization; Cardiac Catheters; Chi-Square Distribution; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Linear Models; Male; Middle Aged; Nicorandil; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Transducers, Pressure; Vasodilator Agents | 2017 |
Nicorandil for maximal hyperemia: a theoretical advantage awaiting clinical significance.
Topics: Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Nicorandil; Vasodilator Agents | 2017 |